Mesothelioma, an aggressive cancer made up of many tumors, is rarely controlled by the body’s natural defenses. Treatment, whether chemotherapy or surgery or another form, is...
Read PostUpdate on Optune Lua: 100-Plus Hospitals Offer the Mesothelioma Therapy
By: Devin Golden
March 4, 2022
Update: This post was updated March 4, 2022, with more hospitals approved to prescribe the Optune Lua therapy for mesothelioma. Optune Lua, the brand name for Novocure’s...
Read PostThe overall median survival figures about immunotherapy versus chemotherapy have been reported often for mesothelioma. A few other pieces of data stress how well the immunotherapy...
Read PostJohnson & Johnson Allowed to Proceed With Bankruptcy Plans in Asbestos Talc Cases
By: Devin Golden
March 2, 2022
A New Jersey bankruptcy court judge ruled in favor of Johnson & Johnson – and against thousands of victims of corporate wrongdoing – by allowing the company to continue...
Read PostOne victim of asbestos won a multi-million-dollar verdict. The court’s ruling feels like a win for many more than just one victim. Former mine worker Ralph H. received a $36.5...
Read PostUpdate (02/25/2022): Judge Michael Kaplan of the U.S. Bankruptcy Court in Trenton, N.J., sided with Johnson & Johnson in the case, according to numerous reports. He denied the...
Read PostMost systemic cancer treatment lasts a set number of cycles. These cycles are usually three-week stretches of time in between sessions of treatment. In most cases, systemic...
Read PostMesothelioma Tumor Microenvironment Dictates Treatment After SMART
By: Devin Golden
February 17, 2022
SMART, the acronym for surgery for mesothelioma after radiation therapy, is a groundbreaking protocol of treatment. Impressive life expectancy of 3-4 years should garnet more...
Read PostDurvalumab and Tremelimumab Are Best Together Than Durvalumab Alone
By: Devin Golden
February 16, 2022
Durvalumab and tremelimumab work so well together for mesothelioma that most patients in a study are still alive two years after starting treatment. Baylor College of Medicine,...
Read PostA new report showed the ethnic and racial disparities in the patient population of oncology clinical trials. Researchers spent December 2020 to April 2021 examining all United...
Read Post